These data suggest that either insulin‐stimulated Akt phosphorylation or AMPK activation by RH‐XOS treatment leads to increase in GLUT4 translocation and enhanced glucose transport into skeletal muscle, which lessens hyperglycemia in T2DM rats. This evidence concerns the gene SLC2A4 and type 2 diabetes mellitus.